TCTR20210428004CompletedPhase 2
Platelet-rich plasma reduces tear size in partial supraspinatus tendon tears compared to conventional steroid injection
/A0 sites29 target enrollmentStarted: April 28, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 29
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 85 Years (—)
- Sex
- All
Inclusion Criteria
- •Age 18-85 years
- •No underlying diseases
- •Diagnosed partial-tear rotator cuff with conservative treatment > 3months
Exclusion Criteria
- •Inflammatory disease
- •Nerve-related symptoms
- •Coagulopathy
Investigators
Similar Trials
Not yet recruiting
Phase 3
Enhancing Scars with Platelet Rich Plasma: A Healthier LookCTRI/2024/01/061196All India Institute of Medical sciences
Recruiting
Phase 4
Rotator cuff tear of shoulder treatment by own blood productCTRI/2019/08/020613COM and JNM hospital
Recruiting
Phase 2
Investigating the Effect of Platelet-Rich Plasma in ArthroscopyIRCT20220803055610N2Tehran University of Medical Sciences20
Completed
Not Applicable
Platelet-rich plasma to reduce air leak after pulmonary resectioAir leak after pulmonary resectionJPRN-UMIN000009352Kansai Medical University10
Completed
Not Applicable
The Healing Effects of Platelet- Rich Plasma on refractory cutaneous uclersrefractory cutaneous uclersJPRN-UMIN000021044Kanazawa University15